Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,361,296
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
20,440,680
-
Shares change
-
-176,384
-
Total reported value, excl. options
-
$55,598,011
-
Value change
-
-$392,205
-
Number of buys
-
12
-
Number of sells
-
-13
-
Price
-
$2.72
Significant Holders of Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) as of Q2 2020
40 filings reported holding CRVS - Corvus Pharmaceuticals, Inc. - Common Stock as of Q2 2020.
Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,440,680 shares
of 74,361,296 outstanding shares and own 27.49% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6,767,584 shares), ADAMS STREET PARTNERS LLC (3,275,616 shares), NOVO Holdings A/S (2,927,560 shares), BVF INC/IL (1,742,112 shares), MILLENNIUM MANAGEMENT LLC (1,192,742 shares), RENAISSANCE TECHNOLOGIES LLC (1,031,900 shares), EcoR1 Capital, LLC (737,612 shares), VANGUARD GROUP INC (574,088 shares), DIMENSIONAL FUND ADVISORS LP (438,383 shares), and CHI Advisors LLC (364,132 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.